AMSTERDAM (Reuters) – The European Medicines Agency (EMA) expects to hold a briefing on the possible side effects of the AstraZeneca coronavirus vaccine on Wednesday at 1600 CET (1400 GMT).
Experts from the European drug authority have reviewed to what extent some cases of blood clotting in adults who had recently received the AstraZeneca vaccine may be linked to the injections.
(Reporting by Bart Meijer; Editing by Hugh Lawson)
Eagles by the Numbers: An inside look at the impressive turnaround of the defense
Cameron Harper, Red Bulls have ‘wrong to right’ in historic East semifinal vs. NYCFC: EXCLUSIVE
Teoscar Hernández – 2024 Phillies Free Agency Big Board
Philadelphia Phillies add 3 prospects to the 40-man roster
Mets acquire Jose Siri from Rays, shore up CF defense while adding power
3rd & B’zaar in East Village offers fresh vendors, vintage treasures and community for all
Queens shootout leaves cop wounded, robbery suspect with lengthy rap sheet dead
City Council committee set to vote on controversial City of Yes residential zoning overhaul
Chinatown leaders urge Council to reject 76ers arena in Center City
Manhattan stabbing spree: More grim details of rampage emerge as suspected killer arraigned on first-degree murder
Prosecution witnesses say Chauvin disregarded training in deadly encounter with George Floyd
Transat’s top shareholder turns down Quebec businessman Peladeau’s offer – The Globe and Mail
U.S. SEC charges actor with operating $690 million Ponzi scheme
WHO says AstraZeneca benefits outweigh risks; assessing latest data
